About Sanofi SA
Sanofi SA, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. It operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation. Its pharmaceuticals portfolio consists of products and a range of prescription medicines, generic medicines and consumer health products. The Vaccines segment is dedicated to vaccines, including research, development, production and marketing. The Animal Health segment includes the research, development, production and marketing activities of Merial, which offers a range of medicines and vaccines for a range of animal species. It operates in the Other segment, which includes the effects of retained commitments. It operates through Regeneron Pharmaceuticals Inc.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Major
- Sub-Industry: N/A
- Exchange: NYSE
- Symbol: SNY
- Previous Close: $42.70
- 50 Day Moving Average: $41.26
- 200 Day Moving Average: $39.81
- 52-Week Range: $36.81 - $44.50
- Trailing P/E Ratio: 21.96
- Foreward P/E Ratio: 13.02
- P/E Growth: 1.97
- Market Cap: $109.56B
- Outstanding Shares: 2,565,800,000
- Beta: 0.98
- Net Margins: 13.66%
- Return on Equity: 26.37%
- Return on Assets: 14.46%
Companies Related to Sanofi SA:
- Debt-to-Equity Ratio: 0.27%
- Current Ratio: 1.47%
- Quick Ratio: 1.00%
What is Sanofi SA's stock symbol?
Sanofi SA trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."
How often does Sanofi SA pay dividends? What is the dividend yield for Sanofi SA?
Sanofi SA announced an annual dividend on Friday, February 17th. Stockholders of record on Monday, May 15th will be paid a dividend of $1.5771 per share on Wednesday, June 7th. This represents a dividend yield of 3.65%. The ex-dividend date of this dividend is Thursday, May 11th. This is a positive change from Sanofi SA's previous annual dividend of $1.10.
Where is Sanofi SA's stock going? Where will Sanofi SA's stock price be in 2017?
14 equities research analysts have issued twelve-month price targets for Sanofi SA's stock. Their forecasts range from $58.00 to $93.00. On average, they anticipate Sanofi SA's stock price to reach $75.50 in the next year.
Who owns Sanofi SA stock?
Sanofi SA's stock is owned by many different of institutional and retail investors. Top institutional investors include Barrow Hanley Mewhinney & Strauss LLC (1.14%), Franklin Resources Inc. (0.82%), Hotchkis & Wiley Capital Management LLC (0.44%), FMR LLC (0.21%), Federated Investors Inc. PA (0.19%) and Senzar Asset Management LLC (0.05%).
Who sold Sanofi SA stock? Who is selling Sanofi SA stock?
Sanofi SA's stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Federated Investors Inc. PA, FMR LLC, Hotchkis & Wiley Capital Management LLC, Baird Financial Group Inc., Franklin Resources Inc., Envestnet Asset Management Inc. and Allianz Asset Management AG.
Who bought Sanofi SA stock? Who is buying Sanofi SA stock?
Sanofi SA's stock was acquired by a variety of institutional investors in the last quarter, including Senzar Asset Management LLC, Paulson & CO. Inc., NWQ Investment Management Company LLC, Willis Investment Counsel, First Bank & Trust, Clark Capital Management Group Inc., Russell Investments Group Ltd. and Glacier Peak Capital LLC.
How do I buy Sanofi SA stock?
Shares of Sanofi SA can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Sanofi SA stock cost?
One share of Sanofi SA stock can currently be purchased for approximately $42.70.